Research articles
ScienceAsia 48 (2022):ID 705-710 |doi:
10.2306/scienceasia1513-1874.2022.099
MiR-647 inhibits proliferation and improves apoptosis in
cisplatin-treated non-small cell lung cancer via
down-regulating IGF2 expression
Min Zhang, Hongjie Zhao, Ling Lin, Zhengang Chen*
ABSTRACT: The purpose of this study was to identify the correlation between MiR-647 and insulin like growth factor
2(IGF2) in non-small cell lung cancer (NSCLC) and their effect on cell proliferation and apoptosis. In the study, A549
cell line was selected as NSCLC cell. The pcDNA3.1-CMV-MiR-647-EGFP and the pcDNA3.1-CMV-IGF2-mCherry were
designed for the overexpression of MiR-647 and IGF2 respectively; while the pAAV-mCherry-shRNA-MiR-647 and the
pAAV-EGFP-shRNA-IGF2 were respectively for MiR-647 and IGF2 knockdown in cisplatin-treated A549 cell line. Ki-67
and caspase-3 were performed to reflect cell proliferation and apoptosis in cisplatin-treated A549 cells. According to
the results, MiR-647 enhanced apoptosis and cell death of cisplatin-treated NSCLC cells in vitro;, and in the cells after
cisplatin treatment and MiR-647 overexpression, a significant decrease of IGF2 expression was presented. Furthermore,
by plasmid transfection in cisplatin-treated A549 cells, we found that IGF2 silence and MiR-647 overexpression could
synergistically promote cell apoptosis and stop NSCLC cell growth. In conclusion, MiR-647 and IGF2 have opposite
effect on NSCLC cell proliferation and apoptosis; that is, MiR-647 can improve NSCLC cell apoptosis via down-regulating
IGF2 expression.
Download PDF
152 Downloads 1103 Views
| a |
Department of Oncology, Tianjin Baodi Hospital, Tianjin 301800 China |
* Corresponding author, E-mail: chzhengang@163.com
Received 22 Oct 2021, Accepted 17 Apr 2022
|
